STD testing market to reach $13.05 billion by 2030 at 8.2% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Sexually Transmitted Diseases (STD) Testing Market In 2026, And How Will Its Value Evolve By 2030?

The sexually transmitted diseases (STD) testing market has shown substantial expansion in recent years. It is anticipated to expand from $8.78 billion in 2025 to $9.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The historical growth in this sector can be attributed to heightened awareness of sexual health, the expansion of public health screening initiatives, enhancements in laboratory diagnostic capabilities, an increase in the prevalence of sexually transmitted infections, and the wider availability of testing services.

The sexually transmitted diseases (std) testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $13.05 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.2%. Several factors are contributing to this growth during the forecast period, including a heightened demand for discreet testing options, increased investment in molecular diagnostics, the broadening availability of telehealth-supported testing, an intensified emphasis on preventive healthcare, and a rise in government programs aimed at disease management. Key trends anticipated during the same period encompass the wider acceptance of at-home STD testing kits, an escalating utilization of molecular diagnostic techniques, the expanding incorporation of digital health platforms, the growth of rapid point-of-care testing, and a stronger concentration on identifying diseases early.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24695&type=smp

What Factors Are Contributing To The Growth Of The Sexually Transmitted Diseases (STD) Testing Market?

An increasing incidence of HIV is expected to drive expansion within the sexually transmitted diseases (STD) testing market in upcoming years. This virus compromises the immune system by targeting and eliminating vital white blood cells, leaving the body more susceptible to various infections and illnesses. A decrease in public awareness and prevention initiatives has contributed to the increase in HIV diagnoses, leading to a rise in risky behaviors like unprotected sexual activity and a decline in testing rates, particularly among younger populations. The growing number of HIV cases fuels the need for sexually transmitted disease (STD) testing by elevating awareness among both the public and healthcare providers, thus encouraging more people to pursue extensive screening for early detection and to halt further spread. Illustratively, data from July 2024 by the Joint United Nations Programme on HIV/AIDS (UNAIDS), a government body based in Switzerland, reported approximately 1.3 million new HIV infections in 2023, a figure almost three times greater than the 2025 goal of fewer than 370,000 cases. Consequently, the expanding prevalence of HIV is set to accelerate the development of the sexually transmitted diseases (STD) testing market.

What Are The Main Segments Within The Sexually Transmitted Diseases (STD) Testing Market Segment Structure?

The sexually transmitted diseases (std) testing market covered in this report is segmented –

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Immunoassay, Molecular Diagnostics

3) By Sample Type: Blood Samples, Urine Samples, Swabs, Semen Samples, Other Sample Types

4) By Disease Type: Chlamydia, Gonorrhea, Syphilis, HIV Or AIDS, Herpes Simplex Virus (HSV)

5) By End User: Individuals, Healthcare Providers, Diagnostic Laboratories, Govement Health Agencies, NGOs And Community Health Organizations

Subsegments:

1) By Instruments And Services: Diagnostic Instruments, Testing Services

2) By Consumables: Reagents And Kits, Specimen Collection Devices, Slides, Tubes

3) By Software: Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR) Integration Tools, Data Analysis And Reporting Tools, Patient Management Software

What Trends Are Shaping The Future Of The Sexually Transmitted Diseases (STD) Testing Market?

Leading companies in the sexually transmitted diseases (STD) testing market are concentrating on developing advanced solutions, such as syphilis testing kits, to broaden access to testing for a wider population. Syphilis testing kits are diagnostic instruments designed to detect the presence of the Treponema pallidum bacteria, which causes syphilis, by analyzing blood samples or other bodily fluids for timely diagnosis and treatment. For example, in August 2023, iHealth Labs Inc., a US-based medical device company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved iHealth CheckMeSafe Home Collection kit allows individuals aged 18 and older to conveniently collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the privacy of their own home. Users can mail their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as quickly as two days. The kit delivers highly accurate results, with sensitivity rates reaching up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

Who Are The Companies Participating In The Sexually Transmitted Diseases (STD) Testing Market?

Major companies operating in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., AEHEALTH LIMITED.

Get The Full Sexually Transmitted Diseases (STD) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-diseases-std-testing-global-market-report

Which Region Leads The Sexually Transmitted Diseases (STD) Testing Market In Overall Market Size?

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted diseases (std) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sexually Transmitted Diseases (STD) Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-diseases-std-testing-global-market-report

Browse Through More Reports Similar to the Global Sexually Transmitted Diseases (STD) Testing Market 2026, By The Business Research Company

Liver Diseases Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Market Report

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Market Report

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795